Skip to main content
Bentham Open Access logoLink to Bentham Open Access
. 2023 Jan 5;26(2):410–423. doi: 10.2174/1386207325666220426083526

Identification of Key Diagnostic Markers and Immune Infiltration in Osteoarthritis

Mingyue Yan 1, Haibo Zhao 1, Zewen Sun 1, Jinli Chen 1, Yi Zhang 1, Jiake Gao 1, Tengbo Yu 1,*
PMCID: PMC10202085  PMID: 35473522

Abstract

Background: Osteoarthritis (OA) is a worldwide chronic disease of the articulating joints. An increasing body of data demonstrates the immune system's involvement in osteoarthritis. The molecular mechanisms of OA are still unclear. This study aimed to search for OA immune-related hub genes and determine appropriate diagnostic markers to help the detection and treatment of the disease.

Methods: Gene expression data were downloaded from the GEO database. Firstly, we analyzed and identified the differentially expressed genes(DEGs)using R packages. Meanwhile, ssGSEA was used to determine the activation degree of immune-related genes (IRGs), and WGCNA analysis was applied to search for co-expressed gene modules associated with immune cells. Then, critical networks and hub genes were found in the PPI network. Gene Ontology (GO) annotation and Kyoto Encyclopedia of Gene and Genomes (KEGG) pathway enrichment analyzed the biological functions of genes. The ability of the hub genes to differentiate OA from controls was assessed by the area under the ROC curve. A miRNA and transcription factor (TF) regulatory network was constructed according to their relationship with hub genes. Finally, the validation of hub genes was carried out by qPCR.

Results: In total, 353 DEGs were identified in OA patients compared with controls, including 222 upregulated and 131 downregulated genes. WGCNA successfully identified 34 main functional modules involved in the pathogenesis of OA. The most crucial functional module involved in OA included 89 genes. 19 immune-related genes were obtained by overlapping DEGs with the darkgrey module. The String database was constructed using the protein-protein interaction (PPI) network of 19 target genes, and 7 hub genes were identified by MCODE. ROC curve showed that 7 hub genes were potential biomarkers of OA. The expression levels of hub genes were validated by qPCR, and the results were consistent with those from bioinformatic analyses.

Conclusion: Immune-related hub genes, including TYROBP, ITGAM, ITGB2, C1QC, MARCO, C1QB, and TLR8, may play critical roles in OA development. ITGAM had the highest correction on immune cells.

Keywords: Osteoarthritis, GEO, immune cells, immune infiltration, bioinformatics, ITGAM

1. INTRODUCTION

Osteoarthritis (OA) is a highly prevalent, age-dependent joint disease, particularly among older people with multiple comorbid illnesses [1]. It is regarded as a multifactorial disease, with common risk factors including age, excess, mechanical loading, and metabolic syndrome [2]. Bone destruction, synovial hyperplasia, osteophyte formation and subchondral bone sclerosis are the main features of osteoarthritis, and the typical symptom is severe joint pain [3]. Specifically, knee osteoarthritis is a painful disease and substantially decreases the life quality of suffered patients [4]. Consequent to unprecedented global population aging, osteoarthritis remains a leading cause of disability, and the treatment often comes at a high cost [5], imposing an enormous economic burden worldwide. Unfortunately, few effective disease-modifying therapies are available due to the unknown etiology and pathological mechanisms. As a consequence, identifying new and effective treatments is vital to improve osteoarthritis outcomes and guide clinical management.

Cumulating evidence supports the pathological roles of immune and inflammatory in the occurrence and development of osteoarthritis [6, 7]. Some studies proposed that altered gene expression in chondrocytes osteoarthritis progression by regulating immune responses [8, 9]. Pro-inflammatory cytokines play a central role in chondrocyte apoptosis and cartilage matrix proteolysis and thus may be implicated in the pathogenesis of osteoarthritis [10]. Previous studies showed that the extent of immune dysregulation significantly correlates with the severity of osteoarthritis, revealing an association between immunity response and clinical manifestations [11]. Therefore, exploring immune infiltration and related diagnostic gene markers in OA will provide a deeper understanding of the pathogenesis of osteoarthritis.

In this study, with the aid of Gene Expression Omnibus (GEO) and bioinformatics, we aimed to describe the characteristics of infiltrating immune cells in osteoarthritis tissues, and comprehensive bioinformatics analyses were performed to explore underlying hub genes. Besides, we constructed a gene-TF-miRNA co-regulatory network according to the relationship among hub genes, TF, and miRNA by bioinformatics methods.

2. MATERIALS AND METHODS

2.1. Data Source

The RNA expression datasets of OA were obtained from Gene Expression Omnibus (GEO) database (https://www.ncbi.nlm.nih.gov/geo/). The gene expression profiles of human knee osteoarthritis tissues were downloaded from GSE114007 (20 OA patients and 18 control individuals) and GSE143514 (5 OA patients and 3 control individuals) for training (Training Set), respectively. The gene expression profiles for validation (Validation Set) were downloaded from GSE98918 (12 OA patients and 12 control individuals).

2.2. Acquirement of Differentially Expressed Genes (DEGs)

Generally, all microarray data after normalization were analyzed by R software. After removing interbatch differences, R package “DESeq2” was used to identify differentially expressed mRNAs between OA and control samples with ∣log2FC| >1 and adj.P.Val < 0.05 as the threshold. The DEGs' heatmap cluster and volcano plots were created using the “heatmap” and “ggplots” packages via R software.

2.3. Functional Annotation and Pathway Enrichment Analysis

GO annotation and KEGG enrichment analysis were performed using the “clusterProfiler” package to reveal the functions of DEGs. The GO functions include biological processes, cellular components, and molecular functions. The KEGG pathway analysis was prone to describe gene function at the genomic and molecular levels and show the correlated genes. P < 0.05 was considered statistically significant.

2.4. Infiltration of Immune Cells

The GEO gene expression profile data were used to quantify the infiltration of immune cells in knee tissues by ssGSEA (Single-sample gene set enrichment analysis), and the infiltration of 28 immune cells was obtained. Each resulting ssGSEA score represents the degree to which the genes in a particular gene set are co-ordinately up or downregulated in each sample in the dataset. The ssGSEA ranked the genes by their absolute expression in a sample, and the enrichment score was calculated by an integration of the differences between the empirical cumulative distribution functions. Furthermore, we performed Spearman correlation analysis on infiltrating immune cells and gene expression by the “ggpubr” package.

2.5. WGCNA

The WGCNAR package was used for weighted gene co-expression network analysis on the GEO expression file. Firstly, samples were clustered to assess the presence of any outliers. Then, the automatic network construction function was used to get the co-expression network. The pickSoftThreshold was used to calculate the soft thresholding power β. Furthermore, hierarchical clustering and the dynamic tree cut function were used to detect different modules. Finally, the Pearson correlation coefficient between the sample vector of variables and the characteristic gene of the module was calculated to measure the degree of association between the clinical features and the modules. We then found out which module of immune cell genes was the most relevant in OA.

2.6. Protein-protein Interaction (PPI) Network Construction

Analysis of the functional interactions between proteins could provide essential insights into the progression of OA. We constructed the PPI network by STRING database (https://string-db.org/). A combined score of >0.4 was considered significant. Cytoscape performed the visualized PPI network. MCODE was used to screen the significant modules in the PPI network. The genes with the highest degree of connectivity in the module were considered hub genes. They were expected to exhibit higher biological significance than the other gene members of the module.

2.7. Validation of Hub Genes

The expression levels of hub genes were uesd to verify whether the hub genes were essential to OA. The “pROC” package was used to perform ROC curve analysis to evaluate the diagnostic value of hub genes for OA, and the area under the curve (AUC) was then computed. The higher the AUC value was, the better the ability of the gene to distinguish whether the sample was diseased or not. The genes with AUC > 0.7 were considered diagnostic genes of OA.

2.8. Correlation Analysis between Hub Genes and Infiltrating Immune Cells

The “ggpubr” package was used to perform Spearman correlation analysis on hub genes and infiltrating immune cells,and the “ggplot2” package was used to visualize the results.

2.9. Multi-factor Regulation Network Construction

We used NetworkAnalyst (https://www.networkanalyst.ca/) and miRNet databases (https://www.mirnet.ca/) to predict the TFs and miRNAs of hub genes. The data of hub genes and their TFs and miRNAs were integrated into a regulatory network and visualized using Cytoscape software.

2.10. RT-PCR Validation of the Hub Genes

To confirm the results of bioinformatics analysis, cartilage tissues of OA patients undergoing knee replacement and normal patients were collected for RT-PCR validation. The study protocol was approved by the Ethics Committee of The Affiliated Hospital of Qingdao University (approval number: QYFY WZLL 26788), and all patients signed the informed consent for tissue collection.

Total RNA of cartilage tissue was extracted with TRIzol reagent (Invitrogen, USA). Those RNA samples were reverse transcribed to cDNA with the PrimeScript RT reagent Kit and subsequently amplified using the TB Green Premix Ex Taq II kit (TaKaRa, Japan). Primer sequences of mRNA were shown in Table 1. The primers of all mRNAs were purchased from ThermoFisher (USA). The gene expression was normalized for GAPDH levels and calculated using the 2−ΔΔCt method. P < 0.05 indicated a significant difference.

Table 1.

Primer sequences of hub genes and Tm values.

Prime Name Sequence Tm
h-GAPDH-F CATGTTCGTCATGGGTGTGAA 59
h-GAPDH-R GGCATGGACTGTGGTCATGAG 60
h-TYROBP-F TTGCAGTTGCTCTACGGTGA 60
h-TYROBP-R TACGCTGTTTCCGGGTCG 60
h-ITGAM-F TGCTGCGCCTGAACTTCTCT 60
h-ITGAM-R GGTCATCCTGGCAGATGTTGT 58
h-ITGB2-F TGGACCGCTACCTCATCTATGTG 60
h-ITGB2-R GGTCGCTCAGGTGGATCAGA 60
h-C1QC-F AGAAGGGAGAACCCGGCTTAC 60
h-C1QC-R ACCGTGAACACTGACTGGAATTT 59
h-MARCO-F ATTGTCTTCTGCCGCATGCT 59
h-MARCO-R GTCATGATGGCCCCAGCTAT 58
h-C1QB-F TGCCACAAGAACCATCAACGT 60
h-C1QB-R CTGGCGTGGTAGGTGAAGTAGTAG 58

3. RESULTS

3.1. Identification of Differentially Expressed Genes (DEGs)

First, the batch effect was removed from the gene expression matrix after merging the GSE114007 and GSE143514 datasets. Then we used the “DESeq2” package to extract a total of 353 DEGs (Supplementary File 1 (357.6KB, pdf) ), including 222 downregulated genes and 131 upregulated genes, which were shown in volcano plots (Fig. 1A). The top 10 upregulated and downregulated DEGs in the visualized heatmap were sorted by the log2FC of DEGs (Fig. 1B).

Fig. (1).

Fig. (1)

Identification of differentially expressed genes (DEGs) in osteoarthritis (OA). (A) Volcano plot of all DEGs in OA. (B) Heat map of the top 10 upregulated and downregulated DEGs in OA.

3.2. GO Annotation and KEGG Pathway Enrichment Analysis of the DEGs

To obtain the functions of these 353 DEGs, GO annotation and KEGG enrichment analysis were conducted using the “clusterProfiler” package. For GO biological process, the DEGs were mainly enriched in regulating the immune effector process, T cell activation, and cell−cell adhesion. In the cellular component, the DEGs were mainly enriched in the collagen-containing extracellular matrix, endocytic vesicles, and the external side of the plasma membrane. The top three significantly enriched terms were receptor ligand activity, signaling receptor activator activity, and amide binding in the molecular function group (Fig. 2A). Besides, the top ten GO terms in each group are listed in Table 2. The result of the KEGG pathway enrichment analysis is shown in Fig. (2B). Leishmaniasis, Staphylococcus aureus infection, and Hematopoietic cell lineage were highly associated with OA. The above results indicated that the DEGs were mainly related to immune-related functions. Additionally, the top ten pathways are listed in Table 3.

Fig (2).

Fig (2)

Functional enrichment analysis of DEGs. (A) GO enrichment of DEGs in GSE114007 and GSE143514 data. GO analysis included 3 functional groups: molecular functions, biological processes, and cell components. (B) KEGG of DEGs in GSE114007 and GSE143514 data.

Table 2.

Top 10 GO analyses results of DEGs and IRGs sorted according to adjusted P-value).

Group Term Gene Count P-value
DEGs Regulation of immune effector process C1QA/C1QB/C1QC/C9/CFI/CLEC12B/CLEC7A/CPN2/FOXJ1/HERC5/HLA-DMB/HLA-DRA/HLA-DRB1/HTRA1/IL6/IRF4/ITGAM/ITGB2/LILRB4/MYB/NOD2/PCK1/PLA2G5/RAC2/RARA/SLAMF6/SLC7A5/TNF/TNFRSF1B/TYROBP/VSIG4/WNT5A 32 8.71E-13
Response to corticosteroid ADM/AGTR2/ALPL/AVPR1A/CDKN1A/COL1A1/CSN1S1/CYBB/DDIT4/ERRFI1/FOSB/GJB2/HSD11B2/IL6/PCK1/STC1/TNF 17 1.52E-10
T cell activation AIF1/CD70/CLEC7A/EGR3/FOXJ1/HES1/HLA-DMB/HLA-DRA/HLA-DRB1/IFNA5/IFNE/IL6/IRF1/IRF4/KIT/LILRB4/MIR27A/MYB/NOD2/PAK3/PAX1/PCK1/PIK3CG/RAC2/RARA/SLAMF6/THY1/TNFRSF1B/VSIG4 29 1.83E-10
Regulation of T cell activation AIF1/CD70/EGR3/FOXJ1/HES1/HLA-DMB/HLA-DRA/HLA-DRB1/IL6/IRF1/IRF4/LILRB4/MIR27A/MYB/NOD2/PAK3/PCK1/RAC2/RARA/THY1/TNFRSF1B/VSIG4 22 5.71E-09
Positive regulation of immune effector process CLEC7A/HLA-DMB/HLA-DRA/HLA-DRB1/IL6/ITGAM/ITGB2/MYB/NOD2/PCK1/PLA2G5/RAC2/RARA/SLAMF6/SLC7A5/TNF/TYROBP/WNT5A 18 6.62E-09
Leukocyte cell-cell adhesion AIF1/CD70/EGR3/FOXJ1/HES1/HLA-DMB/HLA-DRA/HLA-DRB1/IL6/IRF1/ITGB2/LILRB4/MIR27A/MYB/NOD2/PAK3/PCK1/RAC2/RARA/S100A8/THY1/TNF/VSIG4 23 9.26E-09
Reactive oxygen species metabolic process AGTR2/CDKN1A/CLEC7A/CYBB/DDIT4/HBA1/HBA2/HBB/HBD/HBZ/HK2/ITGAM/ITGB2/MT3/PLIN5/PTGS2/RAC2/SESN2/TNF/TYROBP 20 1.12E-08
Regulation of cell-cell adhesion AIF1/CD70/EGR3/FOXJ1/HES1/HLA-DMB/HLA-DRA/HLA-DRB1/IL6/IRF1/ITGB2/LILRB4/MIR27A/MYB/NOD2/PAK3/PCK1/RARA/THY1/TNF/TNR/VEGFA/VSIG4/WNT3A/WNT5A 25 1.35E-08
Response to glucocorticoid ADM/AGTR2/ALPL/AVPR1A/CDKN1A/DDIT4/ERRFI1/FOSB/GJB2/HSD11B2/IL6/PCK1/STC1/TNF 14 1.75E-08
Microglial cell activation AIF1/C1QA/IL6/ITGAM/ITGB2/NR1D1/TLR8/TNF/TYROBP 9 2.98E-08
IRGs Macrophage activation AIF1/ITGAM/ITGB2/TYROBP/VSIG4/TLR8 6 2.61349E-10
Microglial cell activation AIF1/ITGAM/ITGB2/TYROBP/TLR8 5 7.57363E-10
Leukocyte activation involved in inflammatory response AIF1/ITGAM/ITGB2/TYROBP/TLR8 5 7.57363E-10
Glial cell activation AIF1/ITGAM/ITGB2/TYROBP/TLR8 5 2.01495E-09
Positive regulation of superoxide anion generation ITGAM/ITGB2/TYROBP/CLEC7A 4 2.32257E-09
Regulation of superoxide anion generation ITGAM/ITGB2/TYROBP/CLEC7A 4 4.37539E-09
Neuroinflammatory response AIF1/ITGAM/ITGB2/TYROBP/TLR8 5 7.51501E-09
Superoxide anion generation ITGAM/ITGB2/TYROBP/CLEC7A 4 3.49384E-08
Regulation of superoxide metabolic process ITGAM/ITGB2/TYROBP/CLEC7A 4 3.49384E-08
Positive regulation of reactive oxygen species metabolic process AIF1/ITGAM/ITGB2/TYROBP/CLEC7A 5 3.57011E-08

Abbreviations: DEGs: Differentially expressed genes, IRGs: Immune-related genes. “Count” means how many genes are involved.

Table 3.

Top 10 Pathway analyses results of DEGs and IRGs sorted according to adjusted P-value.

Group Term Gene Count P-value
DEGs Leishmaniasis CYBB/FCGR3A/HLA-DMB/HLA-DRA/HLA-DRB1/HLA-DRB5/ITGAM/ITGB2/JUN/PTGS2/TNF 11 2.94E-07
Staphylococcus aureus infection C1QA/C1QB/C1QC/FCGR3A/HLA-DMB/HLA-DRA/HLA-DRB1/HLA-DRB5/CFI/ITGAM/ITGB2 11 2.80E-06
Hematopoietic cell lineage ANPEP/HLA-DMB/HLA-DRA/HLA-DRB1/HLA-DRB5/IL6/IL11/ITGAM/KIT/MME/TNF 11 3.80E-06
Rheumatoid arthritis HLA-DMB/HLA-DRA/HLA-DRB1/HLA-DRB5/IL6/IL11/ITGB2/JUN/TNF/VEGFA 10 1.43E-05
Pertussis C1QA/C1QB/C1QC/IL6/IRF1/ITGAM/ITGB2/JUN/TNF 9 1.77E-05
Inflammatory bowel disease HLA-DMB/HLA-DRA/HLA-DRB1/HLA-DRB5/IL6/JUN/TNF/NOD2 8 3.95E-05
Complement and coagulation cascades C1QA/C1QB/C1QC/C9/CFI/ITGAM/ITGB2/F2RL3/VSIG4 9 4.39E-05
Phagosome CYBB/FCGR3A/HLA-DMB/HLA-DRA/HLA-DRB1/HLA-DRB5/ITGAM/ITGB2/MSR1/MARCO/TUBB3/CLEC7A 12 4.65E-05
TNF signaling pathway IL6/IRF1/JUN/LIF/MMP9/PTGS2/TNF/TNFRSF1B/SOCS3/NOD2 10 7.23E-05
IL-17 signaling pathway FOSB/IL6/JUN/MMP9/MMP13/PTGS2/S100A8/TNF/MAPK15 9 9.73E-05
IRGs Staphylococcus aureus infection C1QB/C1QC/HLA-DMB/HLA-DRB1/ITGAM/ITGB2 6 1.75344E-08
Phagosome HLA-DMB/HLA-DRB1/ITGAM/ITGB2/MARCO/CLEC7A 6 2.76073E-07
Complement and coagulation cascades C1QB/C1QC/ITGAM/ITGB2/VSIG4 5 4.57422E-07
Pertussis C1QB/C1QC/ITGAM/ITGB2 4 1.20992E-05
Leishmaniasis HLA-DMB/HLA-DRB1/ITGAM/ITGB2 4 1.2747E-05
Tuberculosis HLA-DMB/HLA-DRB1/ITGAM/ITGB2/CLEC7A 5 1.86187E-05
Systemic lupus erythematosus C1QB/C1QC/HLA-DMB/HLA-DRB1 4 0.000119669
Cell adhesion molecules HLA-DMB/HLA-DRB1/ITGAM/ITGB2 4 0.000170414
Viral myocarditis HLA-DMB/HLA-DRB1/ITGB2 3 0.000203827
Antigen processing and presentation HLA-DMB/HLA-DRB1/IFI30 3 0.000443376

Abbreviations: DEGs: Differentially expressed genes, IRGs: Immune-related genes. “Count” means how many genes are involved.

3.3. Immune Infiltration Analyses

The difference in the infiltration of 28 immune cells between OA and control was investigated by ssGSEA. The scores of the infiltration of immune cells between OA patients and control were summarized by a heatmap (Fig. 3A). The boxplot showed that 12 immune cells had higher infiltration rates in OA samples (Fig. 3B, P < 0.05).

Fig. (3).

Fig. (3)

The landscape of immune infiltration between OA and controls. (A) The heat map summarizes the immune infiltration score between OA and controls. (B) The difference in immune infiltration between OA and controls. (P-value < 0.05 indicated statistical significance).

3.4. Weighted Co-expression Network Construction and Identification of Key Modules

Pearson’s correlation coefficient was used to cluster the samples. There was no outlier to remove (Fig. 4A). The soft threshold was set to 18 to construct a scale-free network (Fig. 4B). 34 modules were then identified based on average hierarchical clustering and dynamic tree clipping (Fig. 4C). The darkgrey module was highly related to 12 immune cells. Thus, this module, including 89 genes, was selected for further analysis (Fig. 4D).

Fig (4).

Fig (4)

Identification of key modules correlated with immune cells through WGCNA. (A) Clustering dendrograms of samples. (B) Analysis of network topologies for various soft‐thresholding powers through the scale‐free fit index (left) and mean connectivity (right). (C) Clustering dendrogram of genes based on topological overlapping. Different colors were assigned to the corresponding modules. A total of 34 modules were identified. (D) Heatmap of the correlation between module eigengenes and immune cells.

3.5. GO and KEGG Enrichment Analysis of Immune-related Genes

Darkgrey module genes and DEGs were overlapped to obtain 19 immune-related genes (Fig. 5A). Then GO analysis and KEGG analysis of the immune-related genes were conducted. The results showed that the related genes were mainly associated with biological processes such as regulation of immune effector process, positive regulation of leukocyte activation, macrophage activation, and T cell activation. As for GO-CC, the genes were enriched in the external side of the plasma membrane, secretory granule membrane, and MHC protein complex. Meanwhile, regarding GO-MF, the genes were mainly enriched in peptide binding, complement binding, and pattern recognition receptor activity (Fig. 5B). Besides, the top ten GO terms in each group are listed in Table 2 . Finally, the KEGG analysis revealed that the genes were significantly involved in the phagosome, neutrophil extracellular trap formation, and complement and coagulation cascades (Fig. 5C). Additionally, the top ten pathways are listed in Table 3.

Fig. (5).

Fig. (5)

Venn diagram and functional enrichment analysis of immune-related genes. (A) Venn diagram of immune-related genes extracted from DEGs and darkgery modules. (B) GO enrichment of immune-related genes in GSE114007 and GSE143514 data. (C) KEGG of immune-related genes in GSE114007 and GSE143514 data.

3.6. PPI Network Construction and Module Analysis

To further study the interaction of 19 immune-related genes, the PPI network was constructed using by STRING database. With the confidence >0.4 and hiding the disconnected nodes, a visualized PPI network was created by Cytoscape (Fig. 6A). 9 genes in the key module were selected as hub genes using the MCODE plugin (Fig. 6B).

Fig. (6).

Fig. (6)

Construction of PPI network, analysis of key modules, and identification of hub genes. (A) The whole PPI network. (B) PPI network of hub genes.

3.7. Hub Gene Validation

A Receiver Operating Characteristic (ROC) curve was plotted, and the area under the curve (AUC) was calculated to evaluate the diagnostic value of hub genes. The AUCS of 7 hub genes, including TYROBP, ITGAM, ITGB2, C1QC, MARCO, C1QB, and TLR8, were all greater than 0.7 (Fig. 7A). Therefore, these hub genes have a higher diagnostic value as a biomarker.

Fig (7).

Fig (7)

ROC curves for evaluating the accuracy of logistic regression analysis of hub genes. (A) GSE114007 and GSE143514. (B) GSE98918.

Furthermore, the expression levels of the 7 hub genes were examined in GSE98918. The AUC of 7 hub genes was also greater than 0.7 (Fig. 7B). It has been determined that these hub genes could be used as diagnostic markers of OA.

3.8. Correlation Analysis between Hub Genes and Infiltrating Immune Cells

Exploring the relationship between hub genes and immune cells indicated that ITGAM had the highest correction with immune cells. ITGAM was negatively correlated with Type 17 T helper cells and Eosinophils but positively correlated with other immune cells (Fig. 8).

Fig (8).

Fig (8)

Association between hub genes and immune cell infiltration.

3.9. Multi-factor Regulation Network Construction

Based on miRNet and NetworkAnalyst databases, the miRnas hub genes and TFs-hub gene networks were constructed with the help of Cytoscape software (Fig. 9). The network was composed of 7 hub genes, 25 miRNAs, and 36 TFs.

Fig (9).

Fig (9)

Construction of the hub gene-TF-miRNA network in OA.

The hub gene-TF-miRNA network consisted of 7 hub genes (pink ellipse nodes), 25 miRNAs (green rectangle nodes), and 36 TFs (blue diamond nodes).

3.10. RT-PCR Validation of the Hub Genes

Quantitative PCR (qPCR) analyses were performed and showed the relative expression levels of 7 hub genes, including TYROBP, ITGAM, ITGB2, C1QC, MARCO, C1QB and TLR8 (Fig. 10). The results were consistent with those from bioinformatic analyses.

Fig. (10).

Fig. (10)

RT-PCR validation of the hub gene between OA and controls. Each experiment was repeated in triplicate, and the results were presented as M ± SD. (∗p < 0.01, ∗∗p < 0.001).

4. DISCUSSION

Osteoarthritis (OA), especially knee OA, is a chronic disease of the articulating joints, followed by activation of the inflammatory response involving the interaction of cartilage, subchondral bone, and synovium [12], causing joint pain, stiffness, and functional disability in patients worldwide. Previous studies have identified immune cells as significant regulators in the metabolic activities of chondrocytes [12-14]. Therefore, finding immune-related hub genes and diagnostic gene markers to help detect and treat the disease. The present study was conducted to identify 353 DEGs and 19 immune-related genes. A total of 7 hub genes were identified based on the integrated analysis of the PPI network, and ITGAM was indicated to have the highest correction for immune cells. The following analysis also revealed a hub-gene-related TF-miRNA network.

To understand the functions of 353 DEGs, GO annotation and KEGG enrichment analysis were conducted, and found that these genes were associated with immune-related processes. WGCNA revealed 19 immune-related genes, and following enrichment analysis showed that they were mainly associated with biological processes, such as the regulation of the immune effector process, positive regulation of leukocyte activation, macrophage activation, and T cell activation. It was reported that neutrophil elastase released by activated leukocytes could activate MMP-13, PAR2, and a series of cascade reactions, leading to severe cartilage destruction [15, 16]. It was proved that osteophyte formation was related to PAR2 [17, 18]. Suppression of PAR2 would inhibit the apoptosis and senescence of chondrocytes by activating autophagy [19]. Besides, increased macrophage infiltration in the synovium of OA could upregulate the production of anti-inflammatory cytokines such as IL-1 and TNF-α [20, 21]. M1 polarization was associated with the release of R-spondin-2 and the activation of β-catenin signaling, which could exacerbate the progression of osteoarthritis [22]. However, M2 macrophages could inhibit the hypertrophy and apoptosis of chondrocytes, protecting cartilage and promoting cartilage repair [23]. It was also revealed that activated T helper cells would induce osteoclast formation and promote the progression of osteoarthritis by inducing macrophage inflammatory protein-1γ [24]. These genes were also involved in molecular functions, for instance, complement binding and pattern recognition receptor activity. It was found that complement factors, produced and activated in OA joints, suggested an association between the complement alternative pathway components and joint inflammation, supporting the involvement of innate immunity in OA [25]. Besides, pattern recognition receptors could recognize the cellular debris released during chondrocyte degeneration and apoptosis, activating downstream signal pathways and triggering an intense inflammatory response [26, 27]. On the whole, GO annotation and KEGG enrichment analysis indicated a strong correlation between these genes and immune-related processes related to OA progression.

A PPI network was constructed to further study the interaction of 19 immune-related genes. Then, 7 hub genes (TYROBP、ITGAM、ITGB2、C1QC、MARCO、C1QB、TLR8) were identified with AUC> 0.7, which were recognized as diagnostic biomarkers of OA. Exploring the relationship between hub genes and immune cells indicated that ITGAM had the highest correction with immune cells. ITGAM, a marker for total macrophages, was considered a risk factor for systemic lupus erythematosus and possibly a protective factor to rheumatoid arthritis [28]. Meanwhile, ITGAM has been reported to encode CD11b, prevent chondrocyte mineralization, and alleviate OA progression [29, 30]. Besides, TYROBP, together with OSCAR, was proved to regulate the immunoreceptor tyrosine-based activation motif (ITAM) signaling pathway, which was strongly associated with osteoclastogenesis [31]. A study suggested that ITGB2, one of the integrin family, was significantly increased in OA meniscal compared with the control group, consistent with our previous study [32]. Besides, ITGB2 was involved in the phosphate metabolic process, with the clinical observation that meniscal calcification was more severe in OA menisci [33]. It was revealed that C1QB and C1QC, encoding C1q, were increased under inflammatory stimuli relevant to OA, and binding of C1q to chondrocytes would lead to changes in collagen expression with a decrease in type II collagen [34]. MARCO, an M1 macrophage marker, was reported to be significantly associated with early synovitis and the process of including increased trafficking and migration of monocytes into the synovial membrane [35]. A previous study showed that TLR8 expressing M1 macrophages could exacerbate cartilage degeneration in response to a joint injury [36]. Furthermore, when overexpressing human TLR8 in mice, researchers found that huTLR8 would promote the exacerbation of arthritis, and the levels of huTLR8 were related to proinflammatory cytokines in mice joints [37]. As a whole, these hub genes are valuable for being recognized as diagnostic biomarkers of OA. It has also been observed that several studies reported some diagnostic biomarkers in osteoarthritis, which were different from the hub genes found or derived from the same gene family [38-40]. The possible reasons might be the differences in the resources of the datasets analyzed. In any event, further experimental work will be required to test the value of these markers. Finally, we constructed a gene-TF-miRNA co-regulatory network based on the relationship among hub genes, TF, and miRNA, which provides a resource for future mechanistic studies of OA.

Nevertheless, there were several potential limitations to this study. First, the data were obtained mainly from the GEO database, and immune cell infiltration of OA was not validated experimentally. Second, although we performed quality control of the original data, larger samples should be analyzed to validate the results. Finally, further elucidation of related molecular and validation of mechanisms have to be done to provide new ideas for postponing the development of osteoarthritis [41, 42].

CONCLUSION

Overall, this study identified 19 immune-related genes and 7 hub genes, and a TF-miRNA network (7 hub genes, 25 miRNAs, and 36 TFs) was successfully built. ITGAM was found to be significantly related to immune cells in OA. Furthermore, the biological functions and pathways of the identified genes provide a more detailed molecular mechanism of immune infiltration in OA development. Related diagnostic gene markers in OA will help to facilitate our understanding of the mechanisms governing osteoarthritis.

ACKNOWLEDGEMENTS

We thank Zhen Shang for his guidance in the bioinformatics analysis.

LIST OF ABBREVIATIONS

OA

Osteoarthritis

GEO

Gene Expression Omnibus

DEGs

Differentially Expressed Genes

IRGs

Immune-Related Genes

GO

Gene Ontology

KEGG

Kyoto Encyclopedia of Gene and Genomes

PPI

Protein-Protein Interaction

TF

Transcription Factor

ROC

Receiver Operating Characteristics

AUC

Area Under the Curve

DISCLOSURE

The authors declare that they have no competing interests. This research did not receive any specific grants from funding agencies in the public, commercial, or not-for-profit sectors.

AUTHORS’ CONTRIBUTIONS

MY Yan conceived the study design and performed the original manuscript drafting. HB Zhao and ZW Sun were responsible for writing and editing. JL Chen contributed to the acquisition of the data. Yi Zhang and JK Gao contributed to the analysis and interpretation of data. TB Yu was responsible for the conceptualization and supervision of the manuscript. All authors have read and approved the final manuscript.

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

Not applicable.

HUMAN AND ANIMAL RIGHTS

No animals/humans were used for studies that are the basis of this research.

CONSENT FOR PUBLICATION

Not applicable.

AVAILABILITY OF DATA AND MATERIALS

The data supporting the findings of this study are available within the article.

FUNDING

None.

CONFLICT OF INTEREST

None.

SUPPLEMENTARY MATERIAL

Supplementary material is available on the publisher's website along with the published article.

CCHTS-26-410_SD1.pdf (357.6KB, pdf)

REFERENCES

  • 1.Barbour K.E., Helmick C.G., Boring M., Brady T.J. Vital Signs: Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation - United States, 2013-2015. MMWR Morb. Mortal. Wkly. Rep. 2017;66(9):246–253. doi: 10.15585/mmwr.mm6609e1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Vincent T.L. Targeting mechanotransduction pathways in osteoarthritis: A focus on the pericellular matrix. Curr. Opin. Pharmacol. 2013;13(3):449–454. doi: 10.1016/j.coph.2013.01.010. [DOI] [PubMed] [Google Scholar]
  • 3.Mandl L.A. Osteoarthritis year in review 2018: Clinical. Osteoarthritis Cartilage. 2019;27(3):359–364. doi: 10.1016/j.joca.2018.11.001. [DOI] [PubMed] [Google Scholar]
  • 4.Monteagudo S., Cornelis F.M.F., Aznar-Lopez C., Yibman-tasiri P., Guns L.A., Carmeliet P., Cailotto F., Lories R.J. DOT1L safeguards cartilage homeostasis and protects against osteoarthritis. Nat. Commun. 2017;8:15889. doi: 10.1038/ncomms15889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Jüni P., Hari R., Rutjes A.W., Fischer R., Silletta M.G., Reichenbach S., da Costa B.R. Intra-articular corticosteroid for knee osteoarthritis. Cochrane Database Syst. Rev. 2015;10:CD005328. doi: 10.1002/14651858.CD005328.pub3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Robinson W.H., Lepus C.M., Wang Q., Raghu H., Mao R., Lindstrom T.M., Sokolove J. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 2016;12(10):580–592. doi: 10.1038/nrrheum.2016.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wang T., He C. Pro-inflammatory cytokines: The link be-tween obesity and osteoarthritis. Cytokine Growth Factor Rev. 2018;44:38–50. doi: 10.1016/j.cytogfr.2018.10.002. [DOI] [PubMed] [Google Scholar]
  • 8.Zheng L., Wang Y., Qiu P., Xia C., Fang Y., Mei S., Fang C., Shi Y., Wu K., Chen Z., Fan S., He D., Lin X., Chen P. Primary chondrocyte exosomes mediate osteoarthritis pro-gression by regulating mitochondrion and immune reactivity. Nanomedicine (Lond.) 2019;14(24):3193–3212. doi: 10.2217/nnm-2018-0498. [DOI] [PubMed] [Google Scholar]
  • 9.Pemmari A., Leppänen T., Hämäläinen M., Moilanen T., Vuolteenaho K., Moilanen E. Widespread regulation of gene expression by glucocorticoids in chondrocytes from patients with osteoarthritis as determined by RNA-Seq. Arthritis Res. Ther. 2020;22(1):271. doi: 10.1186/s13075-020-02289-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Lin R., Deng C., Li X., Liu Y., Zhang M., Qin C., Yao Q., Wang L., Wu C. Copper-incorporated bioactive glass-ceramics inducing anti-inflammatory phenotype and regenera-tion of cartilage/bone interface. Theranostics. 2019;9(21):6300–6313. doi: 10.7150/thno.36120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Li S., Wan J., Anderson W., Sun H., Zhang H., Peng X. Downregulation of IL-10 secretion by Treg cells in osteoar-thritis is associated with a reduction in Tim-3 expression. Biomed. Pharmacother. 2016;79:159–165. doi: 10.1016/j.biopha.2016.01.036. [DOI] [PubMed] [Google Scholar]
  • 12.Lopes E.B.P., Filiberti A., Husain S.A., Humphrey M.B. Immune contributions to osteoarthritis. Curr. Osteoporos. Rep. 2017;15(6):593–600. doi: 10.1007/s11914-017-0411-y. [DOI] [PubMed] [Google Scholar]
  • 13.Woodell-May J.E., Sommerfeld S.D. Role of inflammation and the immune system in the progression of osteoarthritis. J. Orthop. Res. 2020;38(2):253–257. doi: 10.1002/jor.24457. [DOI] [PubMed] [Google Scholar]
  • 14.Kalaitzoglou E., Griffin T.M., Humphrey M.B. Innate im-mune responses and osteoarthritis. Curr. Rheumatol. Rep. 2017;19(8):45. doi: 10.1007/s11926-017-0672-6. [DOI] [PubMed] [Google Scholar]
  • 15.Kaneva M.K. Neutrophil elastase and its inhibitors-overlooked players in osteoarthritis. FEBS J. 2022;289(1):113–116. doi: 10.1111/febs.16194. [DOI] [PubMed] [Google Scholar]
  • 16.Muley M.M., Reid A.R., Botz B., Bölcskei K., Helyes Z., McDougall J.J. Neutrophil elastase induces inflammation and pain in mouse knee joints via activation of proteinase-activated receptor-2. Br. J. Pharmacol. 2016;173(4):766–777. doi: 10.1111/bph.13237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Lieben L. Osteoarthritis: Osteophyte formation involves PAR2. Nat. Rev. Rheumatol. 2016;12(2):70–71. doi: 10.1038/nrrheum.2016.6. [DOI] [PubMed] [Google Scholar]
  • 18.Huesa C., Ortiz A.C., Dunning L., McGavin L., Bennett L., McIntosh K., Crilly A., Kurowska-Stolarska M., Plevin R., van ’t Hof R.J., Rowan A.D., McInnes I.B., Goodyear C.S., Lockhart J.C., Ferrell W.R. Proteinase-activated receptor 2 modulates OA-related pain, cartilage and bone pathology. Ann. Rheum. Dis. 2016;75(11):1989–1997. doi: 10.1136/annrheumdis-2015-208268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Huang X., Ni B., Xi Y., Chu X., Zhang R., You H. Prote-ase-activated receptor 2 (PAR-2) antagonist AZ3451 as a novel therapeutic agent for osteoarthritis. Aging (Albany NY) 2019;11(24):12532–12545. doi: 10.18632/aging.102586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ni Z., Kuang L., Chen H., Xie Y., Zhang B., Ouyang J., Wu J., Zhou S., Chen L., Su N., Tan Q., Luo X., Chen B., Chen S., Yin L., Huang H., Du X., Chen L. The exosome-like vesicles from osteoarthritic chondrocyte enhanced ma-ture IL-1β production of macrophages and aggravated syno-vitis in osteoarthritis. Cell Death Dis. 2019;10(7):522. doi: 10.1038/s41419-019-1739-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Cui Z., Crane J., Xie H., Jin X., Zhen G., Li C., Xie L., Wang L., Bian Q., Qiu T., Wan M., Xie M., Ding S., Yu B., Cao X. Halofuginone attenuates osteoarthritis by inhibi-tion of TGF-β activity and H-type vessel formation in sub-chondral bone. Ann. Rheum. Dis. 2016;75(9):1714–1721. doi: 10.1136/annrheumdis-2015-207923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Zhang H., Lin C., Zeng C., Wang Z., Wang H., Lu J., Liu X., Shao Y., Zhao C., Pan J., Xu S., Zhang Y., Xie D., Cai D., Bai X. Synovial macrophage M1 polarisation exacerbates experimental osteoarthritis partially through R-spondin-2. Ann. Rheum. Dis. 2018;77(10):1524–1534. doi: 10.1136/annrheumdis-2018-213450. [DOI] [PubMed] [Google Scholar]
  • 23.Dai M., Sui B., Xue Y., Liu X., Sun J. Cartilage repair in degenerative osteoarthritis mediated by squid type II collagen via immunomodulating activation of M2 macrophages, inhib-iting apoptosis and hypertrophy of chondrocytes. Biomaterials. 2018;180:91–103. doi: 10.1016/j.biomaterials.2018.07.011. [DOI] [PubMed] [Google Scholar]
  • 24.Shen P.C., Wu C.L., Jou I.M., Lee C.H., Juan H.Y., Lee P.J., Chen S.H., Hsieh J.L. T helper cells promote disease progression of osteoarthritis by inducing macrophage in-flammatory protein-1γ. Osteoarthritis Cartilage. 2011;19(6):728–736. doi: 10.1016/j.joca.2011.02.014. [DOI] [PubMed] [Google Scholar]
  • 25.Assirelli E., Pulsatelli L., Dolzani P., Mariani E., Lisignoli G., Addimanda O., Meliconi R. Complement Expression and Activation in Osteoarthritis Joint Compartments. Front. Immunol. 2020;11:535010. doi: 10.3389/fimmu.2020.535010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kalchishkova N., Fürst C.M., Heinegård D., Blom A.M. NC4 Domain of cartilage-specific collagen IX inhibits com-plement directly due to attenuation of membrane attack for-mation and indirectly through binding and enhancing activity of complement inhibitors C4B-binding protein and factor H. J. Biol. Chem. 2011;286(32):27915–27926. doi: 10.1074/jbc.M111.242834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Yamasaki K., Muto J., Taylor K.R., Cogen A.L., Audish D., Bertin J., Grant E.P., Coyle A.J., Misaghi A., Hoffman H.M., Gallo R.L. NLRP3/cryopyrin is necessary for interleu-kin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J. Biol. Chem. 2009;284(19):12762–12771. doi: 10.1074/jbc.M806084200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ramírez-Bello J., Sun C., Valencia-Pacheco G., Singh B., Barbosa-Cobos R.E., Saavedra M.A., López-Villanueva R.F., Nath S.K. ITGAM is a risk factor to systemic lupus erythematosus and possibly a protection factor to rheumatoid arthritis in patients from Mexico. PLoS One. 2019;14(11):e0224543. doi: 10.1371/journal.pone.0224543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Hom G., Graham R.R., Modrek B., Taylor K.E., Ortmann W., Garnier S., Lee A.T., Chung S.A., Ferreira R.C., Pant P.V., Ballinger D.G., Kosoy R., Demirci F.Y., Kamboh M.I., Kao A.H., Tian C., Gunnarsson I., Bengtsson A.A., Rantapää-Dahlqvist S., Petri M., Manzi S., Seldin M.F., Rönnblom L., Syvänen A.C., Criswell L.A., Gregersen P.K., Behrens T.W. Association of systemic lupus erythema-tosus with C8orf13-BLK and ITGAM-ITGAX. N. Engl. J. Med. 2008;358(9):900–909. doi: 10.1056/NEJMoa0707865. [DOI] [PubMed] [Google Scholar]
  • 30.Ehirchiou D., Bernabei I., Chobaz V., Castelblanco M., Hügle T., So A., Zhang L., Busso N., Nasi S. CD11b sig-naling prevents chondrocyte mineralization and attenuates the severity of osteoarthritis. Front. Cell Dev. Biol. 2020;86:11757. doi: 10.3389/fcell.2020.611757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ascone G., Di Ceglie I., Walgreen B., Sloetjes A.W., Lind-hout E., Bot I., van de Loo F.A.J., Koenders M.I., van der Kraan P.M., Blom A.B., van den Bosch M.H.J., van Lent P.L.E.M. High LDL levels lessen bone destruction during an-tigen-induced arthritis by inhibiting osteoclast formation and function. Bone. 2020;130:115140. doi: 10.1016/j.bone.2019.115140. [DOI] [PubMed] [Google Scholar]
  • 32.Sun Y., Mauerhan D.R., Honeycutt P.R., Kneisl J.S., Nor-ton J.H., Hanley E.N., Jr, Gruber H.E. Analysis of meniscal degeneration and meniscal gene expression. BMC Musculoskelet. Disord. 2010;11:19. doi: 10.1186/1471-2474-11-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Canhão H., Fonseca J.E., Leandro M.J., Romeu J.C., Pi-mentão J.B., Costa J.T., Queiroz M.V. Cross-sectional study of 50 patients with calcium pyrophosphate dihydrate crystal arthropathy. Clin. Rheumatol. 2001;20(2):119–122. doi: 10.1007/s100670170081. [DOI] [PubMed] [Google Scholar]
  • 34.Lubbers R., van Schaarenburg R.A., Kwekkeboom J.C., Levarht E.W.N., Bakker A.M., Mahdad R., Monteagudo S., Cherifi C., Lories R.J., Toes R.E.M., Ioan-Facsinay A., Trouw L.A. Complement component C1q is produced by isolated articular chondrocytes. Osteoarthritis Cartilage. 2020;28(5):675–684. doi: 10.1016/j.joca.2019.09.007. [DOI] [PubMed] [Google Scholar]
  • 35.Sieker J.T., Ayturk U.M., Proffen B.L., Weissenberger M.H., Kiapour A.M., Murray M.M. Immediate administra-tion of intraarticular triamcinolone acetonide after joint injury modulates molecular outcomes associated with early synovi-tis. Arthritis Rheumatol. 2016;68(7):1637–1647. doi: 10.1002/art.39631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Mendez M.E., Sebastian A., Murugesh D.K., Hum N.R., McCool J.L. Hsia, AW LPS-induced inflammation prior to in-jury exacerbates the development of post-traumatic osteoar-thritis in mice. J. Bone Miner. Res. 2020;35(11):2229–2241. doi: 10.1002/jbmr.4117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Guiducci C., Gong M., Cepika A.M., Xu Z., Tripodo C., Bennett L., Crain C., Quartier P., Cush J.J., Pascual V., Coffman R.L., Barrat F.J. RNA recognition by human TLR8 can lead to autoimmune inflammation. J. Exp. Med. 2013;210(13):2903–2919. doi: 10.1084/jem.20131044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Han Y., Wu J., Gong Z., Zhou Y., Li H., Wang B., Qian Q. Identification and development of a novel 5-gene diagnos-tic model based on immune infiltration analysis of osteoar-thritis. J. Transl. Med. 2021;19(1):522. doi: 10.1186/s12967-021-03183-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Cao J., Ding H., Shang J., Ma L., Wang Q., Feng S. Weighted gene co-expression network analysis reveals specif-ic modules and hub genes related to immune infiltration of osteoarthritis. Ann. Transl. Med. 2021;9(20):1525. doi: 10.21037/atm-21-4566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Tang C., Liu Q., Zhang Y., Liu G., Shen G. Identification of CIRBP and TRPV4 as immune-related diagnostic bi-omarkers in osteoarthritis. Int. J. Gen. Med. 2021;14:10235–10245. doi: 10.2147/IJGM.S342286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Fedorov D.G., Li H., Mironov V., Alexeev Y. Computa-tional methods for biochemical simulations implemented in GAMESS. Methods Mol. Biol. 2020;2114:123–142. doi: 10.1007/978-1-0716-0282-9_8. [DOI] [PubMed] [Google Scholar]
  • 42.Allec S.I., Sun Y., Sun J., Chang C.A., Wong B.M. Hetero-geneous CPU+GPU-enabled simulations for DFTB molecular dynamics of large chemical and biological systems. J. Chem. Theory Comput. 2019;15(5):2807–2815. doi: 10.1021/acs.jctc.8b01239. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary material is available on the publisher's website along with the published article.

CCHTS-26-410_SD1.pdf (357.6KB, pdf)

Data Availability Statement

The data supporting the findings of this study are available within the article.


Articles from Combinatorial Chemistry & High Throughput Screening are provided here courtesy of Bentham Science Publishers

RESOURCES